Natural Killer Cells - Their Role in Tumour Immunosurveillance

Preeti Sharma1, Pradeep Kumar2, Rachna Sharma3

  • 1Associate Professor, Department of Biochemistry, Santosh Medical University, Ghaziabad, Uttar Pradesh, India.

Insights

Natural killer (NK) cells, a part of the innate immune system, show great promise for cancer therapy. Researchers are exploring strategies to enhance NK cell efficacy against various cancers, despite existing challenges.

Area of Science:

  • Immunology
  • Oncology
  • Cell Biology

Background:

  • Natural killer (NK) cells are crucial components of the innate immune system originating from the lymphoid lineage.
  • NK cells possess the unique ability to eliminate cancerous and virally infected cells while sparing healthy ones.
  • They also play a role in augmenting adaptive immunity through cytokine-mediated interactions.

Purpose of the Study:

  • To explore the therapeutic potential of Natural Killer (NK) cells in cancer treatment.
  • To review the mechanisms by which NK cells combat cancer and modulate immune responses.
  • To discuss current strategies and challenges in enhancing NK cell-based cancer therapies.

Main Methods:

  • Review of scientific literature on NK cell biology and function.
  • Analysis of NK cell receptor-ligand interactions and cytokine signaling pathways.
  • Examination of various strategies employed to augment NK cell activity for therapeutic purposes.

Main Results:

  • NK cells demonstrate potent cytotoxic activity against diverse cancer types, including antibody-coated, tumor, and genotoxically damaged cells.
  • NK cells enhance adaptive immunity by promoting the differentiation, activation, and recruitment of other immune cells.
  • Advances in understanding NK cell mechanisms allow for tailored modulation of their activity to achieve clinically relevant responses.

Conclusions:

  • NK cells represent a promising therapeutic avenue for various cancers due to their targeted cytotoxicity and immune-modulating capabilities.
  • Current research focuses on optimizing NK cell-based strategies through understanding their intricate regulatory mechanisms.
  • Further research is needed to overcome existing challenges and fully realize the therapeutic potential of NK cells in oncology.

Related Concept Videos

Immune Surveillance by NK Cells and Phagocytes01:25

Immune Surveillance by NK Cells and Phagocytes

Immune surveillance is an integral part of the innate immune system, involving the continuous monitoring of peripheral tissues to detect and respond to pathogens, infected cells, or cancerous cells. This surveillance is conducted primarily by natural killer (NK) cells and phagocytes, which employ distinct but complementary mechanisms to identify and eliminate threats.
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...
9.0K
Cells of the Innate Immune Response01:28

Cells of the Innate Immune Response

The innate immune response is an immediate and non-specific response against pathogens, acting swiftly to prevent the spread of infections. The primary cells involved in this response are phagocytes and natural killer (NK) cells.
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
9.7K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
7.6K